Skip to content

Clinical course and burden of disease of lower respiratory tract infections in primary care

Clinical course and burden of disease of lower respiratory tract infections in primary care - Burden of disease of LRTI in general Practice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36564
Enrollment
500
Registered
2010-12-17
Start date
2011-12-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower respiratory tract infections pneumonia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Male or female adults aged 50 years or older 2.Registered with a GP who is participating in the study 3.an acute cough lasting for at least 3 days 4.Symptoms/signs suggestive of CAP or other LRTI (see protocol section 2: Definitions) 5.able to fill in a diary

Exclusion criteria

Exclusion criteria: 1.Residence in a nursing home, long-term care facility or other institution, with requirement of semiskilled nursing care. 2.Immune deficiency or suppression, defined as presence of immunocompromising disease or chronic use of immunosuppressive drugs (for prednisone low doses are allowed). 3. Hospitalisation within 7 days preceding date of inclusion 4. Severity of illness requiring hospitalisation on date of inclusion 5. Use of systemic antibiotic drugs within 14 days preceding date of inclusion See protocol paragraph 5.3 Exclusion criteria

Design outcomes

Primary

MeasureTime frame
Primary endpoint: duration of symptoms of CAP and other LRTI.

Secondary

MeasureTime frame
Secondary endpoints: complications of CAP and other LRTI, quality of life and daily activities, number of infections with Streptococcus pneumoniae, number of infections with other bacterial pathogens (Haemophilus influenzae, Moraxella catharralis, Mycoplasma pneumoniae).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)